Back to Rankings

RGC

Regencell BioscienceC
Nasdaq / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
At close
2026-07-22
View Chart
+
Peers tracked
11
U.S. public peers
Grade Position
In line
vs peer average
RGC vs peer average
49/100
RGC vs. peer average (C vs. C)
Grade spread
A 1 · B 3 · C 3 · D 4
Graded peers loaded
Coverage
11 graded
100% of tracked

Peer overview

CRSP is the first available peer comparator.

Gene-editing/biotech peer with advanced clinical programs; useful qualitative comparator for development-stage biotech investor interest.

Peer source comes from the stored AI memo or peer model
Grades and factor rows use RankAlpha API data when available
Missing peer scores remain blank instead of being estimated
Side-by-side comparison keeps the data contract visible
Top peerCRSPCRISPR Therapeutics
RGC
Regencell Bioscience
CRSP
CRISPR Therapeutics
Grade
C
B
Momentum
1
20
Value
41
41
Sentiment
100
100
Setup Bias
Net —
-
Market Cap
-
-
Posture
Mixed
Constructive

Grade position vs CRSP

RGC / CRSP
Grade Position
In line
RGC vs. peer average (C vs. C)
49/100
Momentum
1
CRSP
Value
41
RGC
Sentiment
100
RGC

Rotation landscape

Peers ranked by the order returned from the peer source, with grades from the API.

Rank
Ticker
Company
Grade
Grade score
vs RGC
1
CRSP
CRSP
B
80/100
-1
2
EDIT
EDIT
B
80/100
-1
3
ALKS
ALKS
A
100/100
-2
4
GRAL
GRAIL Inc Common
D
40/100
+1
5
IRON
Disc Medicine Inc Common
D
40/100
+1
CRSP is the first peer returned for this comparison set.